Manufacturing

Feliza Mirasol is the science editor for 

Articles

Advancements in bioprocessing technologies test microbial fermentation adaptability.

Bioprocessing Innovations Pose New Challenges for Fermentation

Nirupama (Rupa) Pike, PhD, is director of Enterprise Science and Innovation Partnerships at Thermo Fisher Scientific.

The industry considers applying automation and digitalization lessons learned during the COVID-19 pandemic to enhance workflows. 

Reevaluating Cell and Gene Therapy Development

Jennifer Markarian is manufacturing editor of BioPharm International.

Mechanistic models provide process understanding for developing robust manufacturing processes and for scale up and tech transfer.

Using Digital Twins to Model Process Chromatography

Models of biopharmaceutical processes can be used for speeding development and improving process control. 

Opportunities for Digital Twins

Eli Lilly and Company and industry partners, including Ziath, are focused on speeding up the drug discovery process with a fully automated lab.

Next-Gen Automation Lab Aims to Speed Up Drug Discovery Process

Lonza and Sheba Medical Center have successfully dosed four patients with a CD19 autologous CAR-T cell therapy using Lonza’s Cocoon automated manufacturing platform.

Lonza and Sheba Medical Center Demonstrate Successful Cell Therapy Results with Cocoon Automated Platform

SP Scientific Products’ SP Hull LyoStar 4.0 R&D freeze dryer supports rapid freeze-dry cycle development, optimization, and process scale-up.

New Pilot-Scale Lyophilizer Aids Biologics Drug Development

Horiba has joined a consortium aimed at accelerating the development of process analytical technologies for cell and gene therapy manufacturing

Horiba Joins CGT Catapult Consortium to Accelerate Development of PAT

Optima has teamed up with the Robert-Bosch-Krankenhaus and Heidelberg University to develop a unit for decentralized, automated production of CAR-T cell therapies.

Optima Teams Up with Clinics to Develop Production Unit for CAR-T Cell Therapies

The CGT Catapult has formed a consortium aimed at advancing the technology development and lowering costs of cell and gene therapy manufacturing.

Process Control, Automation, and PAT